Related Experiment Videos
Why monitor peak vancomycin concentrations?
1Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Lancet (London, England)
|December 24, 1994
Summary
Monitoring vancomycin therapy can focus on trough concentrations. If trough levels stay below 15 mg/L, peak vancomycin levels are unlikely to exceed safe limits, simplifying patient management.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Infectious Diseases
Background:
- Vancomycin therapy requires therapeutic drug monitoring.
- Peak and trough serum concentrations guide vancomycin dosing.
- Trough concentrations are critical for efficacy and safety.
Purpose of the Study:
- To determine post-dose increases in vancomycin serum concentrations.
- To evaluate the necessity of measuring peak vancomycin levels in routine practice.
- To establish a relationship between trough and peak concentrations in patients without renal failure.
Main Methods:
- Analysis of 165 paired serum samples from adult patients.
- Measurement of vancomycin concentrations post-infusion.
- Focus on patients without renal impairment.
- Collection of peak samples 1 hour post-infusion.
Main Results:
- The mean increase in serum vancomycin concentration was 16.6 mg/L (SD 6.1).
- A significant correlation exists between post-dose increases and established therapeutic ranges.
- Peak concentrations remained within safe limits when troughs were below 15 mg/L.
Conclusions:
- Measuring peak vancomycin levels may be unnecessary in routine clinical practice.
- Trough concentration monitoring is sufficient for optimizing vancomycin therapy.
- Simplified vancomycin monitoring protocols can be implemented based on trough levels.